<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>This paper analyzes the hematologic features and outcome of 13 patients with chromosome 5 abnormalities (<z:mp ids='MP_0004026'>monosomy</z:mp> 5 or deletion of 5q), either isolated or with additional anomalies </plain></SENT>
<SENT sid="1" pm="."><plain>Among four patients with isolated del (5q), two had a stable <z:hpo ids='HP_0004861'>refractory macrocytic anemia</z:hpo> with <z:hpo ids='HP_0001894'>thrombocytosis</z:hpo> (<z:e sem="disease" ids="C0740302" disease_type="Disease or Syndrome" abbrv="">5q-syndrome</z:e>) </plain></SENT>
<SENT sid="2" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> nine patients with complex karyotypes had <z:hpo ids='HP_0002488'>acute leukemia</z:hpo> or <z:hpo ids='HP_0005505'>refractory anemia</z:hpo> with excess of blasts in <z:hpo ids='HP_0011009'>acute</z:hpo> transformation; two cases were TdT-positive, with a lymphoid or a mixed phenotype </plain></SENT>
<SENT sid="3" pm="."><plain>In seven patients, <z:e sem="disease" ids="C0026986,C0033027" disease_type="Neoplastic Process" abbrv="">preleukemia</z:e> preceded overt <z:hpo ids='HP_0001909'>leukemia</z:hpo>, and in six, a prior therapeutic, or occupational exposure to <z:chebi fb="1" ids="25435">mutagens</z:chebi>/carcinogens had occurred </plain></SENT>
<SENT sid="4" pm="."><plain>Additional chromosome 7 abnormalities were seen in four cases </plain></SENT>
<SENT sid="5" pm="."><plain>The median survival of patients with complex karyotypes was 19 months from the time of diagnosis of the <z:e sem="disease" ids="C1521860" disease_type="Disease or Syndrome" abbrv="">hematologic disorder</z:e> and 5 months from the time of identification of the chromosome 5 abnormality </plain></SENT>
<SENT sid="6" pm="."><plain>Pathogenetic implications of the chromosome 5 <z:mp ids='MP_0004026'>monosomy</z:mp> or del (5q) through a proto-oncogene activation and the putative hemopoietic stem cell involvement in a clonal disease are discussed </plain></SENT>
</text></document>